ampicillin has been researched along with Obesity in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Aftab, N; Eijaz, S; Hanif, U; Iqbal, R; Liaqat, I; Naseem, S; Rubab, S | 1 |
| Adeshirlarijaney, A; Chassaing, B; Gewirtz, AT; Tran, HQ; Zou, J | 1 |
| Azmy, V; Benson, J; Love, K; Steele, R | 1 |
| Chaix, A; Chang, MW; Knight, R; Marotz, CA; Panda, S; Saghatelian, A; Xu, ZZ; Zarrinpar, A | 1 |
| Ellekilde, M; Hansen, AK; Hansen, CH; Josefsen, K; Kihl, P; Lykkesfeldt, J; Nielsen, DS; Rolin, BC; Rune, I; Skovgaard, K; Tranberg, B | 1 |
| Bomhof, MR; Eller, LK; Geuking, MB; Paul, HA; Reimer, RA | 1 |
| Blancher, F; Chou, CJ; Membrez, M | 1 |
| Culha, G; Guler, SA; Gulluoglu, BM; Ugurlu, MU | 1 |
| Bibiloni, R; Blancher, F; Burcelin, RG; Cani, PD; Chou, CJ; Corthesy, I; Jaquet, M; Macé, K; Membrez, M | 1 |
| Bishop, EH; Green, SL; Sarubbi, FA | 1 |
| Meares, EM | 1 |
2 review(s) available for ampicillin and Obesity
| Article | Year |
|---|---|
Gut decontamination with norfloxacin and ampicillin enhances insulin sensitivity in mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Blood Glucose; Cecum; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Insulin; Lipid Metabolism; Liver; Mice; Mice, Obese; Norfloxacin; Obesity | 2008 |
Factors that influence surgical wound infections. Role of prophylactic antibiotic therapy.
Topics: Age Factors; Ampicillin; Animals; Anti-Bacterial Agents; Bacitracin; Cephaloridine; Diabetes Complications; Drainage; Gloves, Surgical; Guinea Pigs; Hexachlorophene; Humans; Intestines; Kanamycin; Length of Stay; Neomycin; Nutrition Disorders; Obesity; Penicillins; Staphylococcal Infections; Surgical Wound Infection; Ultraviolet Rays | 1975 |
1 trial(s) available for ampicillin and Obesity
| Article | Year |
|---|---|
Efficacy of prophylactic antibiotic administration for breast cancer surgery in overweight or obese patients: a randomized controlled trial.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Breast Neoplasms; Cost-Benefit Analysis; Double-Blind Method; Drug Administration Schedule; Female; Hospital Costs; Humans; Injections, Intravenous; Intention to Treat Analysis; Mastectomy; Middle Aged; Obesity; Overweight; Preoperative Care; Risk Factors; Sulbactam; Surgical Wound Infection; Turkey | 2013 |
8 other study(ies) available for ampicillin and Obesity
| Article | Year |
|---|---|
Impact of Interplay between Obese Gut Microbiota and Diet in Developing Obesity in Synthetic Community Mice.
Topics: Ampicillin; Animal Feed; Animals; Diet, High-Fat; Disease Models, Animal; Escherichia coli; Gastrointestinal Microbiome; Humans; Klebsiella oxytoca; Lipid Metabolism; Mice; Microbiota; Morganella morganii; Obesity; Pseudomonas aeruginosa; Staphylococcus; Weight Gain | 2021 |
Amelioration of metabolic syndrome by metformin associates with reduced indices of low-grade inflammation independently of the gut microbiota.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Diet, High-Fat; Fatty Liver; Gastrointestinal Microbiome; Germ-Free Life; Hyperglycemia; Hypoglycemic Agents; Inflammation; Liver; Metabolic Syndrome; Metformin; Mice; Neomycin; Obesity | 2019 |
Idiopathic nonhistaminergic acquired angioedema in a patient with coronavirus disease 2019.
Topics: Adenosine Monophosphate; Adult; Alanine; Ampicillin; Angioedema; Betacoronavirus; Coronavirus Infections; COVID-19; Diabetes Mellitus, Type 2; Female; Humans; Hydroxychloroquine; Hyperlipidemias; Intubation, Intratracheal; Obesity; Pandemics; Pneumonia, Viral; Respiration, Artificial; Respiratory Insufficiency; SARS-CoV-2; Treatment Outcome | 2020 |
Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Bile Acids and Salts; Blood Glucose; Body Composition; Body Weight; Cecum; Colon; Fatty Acids, Volatile; Gastrointestinal Microbiome; Gene Expression Regulation; Glucose; Homeostasis; Insulin; Insulin Resistance; Male; Metronidazole; Mice; Mice, Inbred C57BL; Neomycin; Obesity; RNA, Ribosomal, 16S; Vancomycin | 2018 |
Ampicillin-improved glucose tolerance in diet-induced obese C57BL/6NTac mice is age dependent.
Topics: Ampicillin; Animals; Blood Glucose; Dendritic Cells; Diet, High-Fat; Gastrointestinal Tract; Glucose Intolerance; Glucose Tolerance Test; Mice; Mice, Inbred C57BL; Mice, Obese; Microbiota; Obesity; T-Lymphocytes, Regulatory | 2013 |
Improvement in adiposity with oligofructose is modified by antibiotics in obese rats.
Topics: Adiposity; Ampicillin; Animals; Anti-Bacterial Agents; Bacteria; Blood Glucose; Energy Intake; Glucose Tolerance Test; Male; Neomycin; Obesity; Oligosaccharides; Rats; Rats, Sprague-Dawley; RNA, Ribosomal, 16S | 2016 |
Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides; Bifidobacterium; Diabetes Mellitus, Type 2; Enterobacteriaceae; Lactobacillus; Mice; Mice, Obese; Microbial Sensitivity Tests; Norfloxacin; Obesity | 2008 |
Prophylactic antibiotics in high-risk cesarean section.
Topics: Ampicillin; Anesthesia, General; Cesarean Section; Female; Fever; Hematocrit; Humans; Labor, Obstetric; Obesity; Postoperative Complications; Pregnancy; Puerperal Infection; Risk; Time Factors | 1978 |